(Total Views: 524)
Posted On: 04/16/2020 5:36:11 PM
Post# of 154003
Re: Crujones1985 #28160
They have three trials plus the two canceled in China ):
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Open Label
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
Open Label
Expanded Access Remdesivir (RDV; GS-5734™)
Expanded access
No randomized with quadruple masking studies like us.
Some are more "equal" than others
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Open Label
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
Open Label
Expanded Access Remdesivir (RDV; GS-5734™)
Expanded access
No randomized with quadruple masking studies like us.
Some are more "equal" than others
(1)
(0)
